Literature DB >> 22856395

Protective effect of Korean red ginseng extract on the infections by H1N1 and H3N2 influenza viruses in mice.

Dae-Goon Yoo1, Min-Chul Kim, Min-Kyung Park, Jae-Min Song, Fu-Shi Quan, Kyoung-Mi Park, Young-Keol Cho, Sang-Moo Kang.   

Abstract

Ginseng has been used in humans for thousands of years and is known to have multiple biological and immunomodulatory effects. In this study, we investigated whether Korean red ginseng extract would have preventive and antiviral effects on influenza virus infection. Oral administration to mice of red ginseng extract prior to infection significantly increased survival after infection with the 2009 pandemic H1N1 virus. Daily oral treatment of vaccinated mice with red ginseng extract provided enhanced cross-protection against antigenically distinct H1N1 and H3N2 influenza viruses. Naive mice that were infected with virus mixed with red ginseng extract showed significantly enhanced protection, lower levels of lung viral titers and interleukin-6, but higher levels of interferon-γ compared with control mice having virus infections without red ginseng extract, indicating an antiviral effect of ginseng. In addition, ginseng extract exhibited inhibitory effects on the growth of influenza virus in vitro. This study provides evidence that intake of ginseng extract will have beneficial effects on preventing lethal infection with newly emerging influenza viruses.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22856395      PMCID: PMC3466917          DOI: 10.1089/jmf.2012.0017

Source DB:  PubMed          Journal:  J Med Food        ISSN: 1096-620X            Impact factor:   2.786


  44 in total

1.  Changes in in vitro susceptibility of influenza A H3N2 viruses to a neuraminidase inhibitor drug during evolution in the human host.

Authors:  Catherine I Thompson; Wendy S Barclay; Maria C Zambon
Journal:  J Antimicrob Chemother       Date:  2004-03-17       Impact factor: 5.790

2.  Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age.

Authors:  Robert B Belshe; Christopher S Ambrose; Tingting Yi
Journal:  Vaccine       Date:  2008-09-12       Impact factor: 3.641

3.  The immunomodulator ginsan induces resistance to experimental sepsis by inhibiting Toll-like receptor-mediated inflammatory signals.

Authors:  Ji-Yeon Ahn; In-Soo Choi; Ji-Young Shim; Eun-Kyung Yun; Yeon-Sook Yun; Gajin Jeong; Jie-Young Song
Journal:  Eur J Immunol       Date:  2006-01       Impact factor: 5.532

4.  Chemical and pharmacological studies of saponins with a focus on American ginseng.

Authors:  Chun-Su Yuan; Chong-Zhi Wang; Sheila M Wicks; Lian-Wen Qi
Journal:  J Ginseng Res       Date:  2010-09-01       Impact factor: 6.060

5.  Virus-like particle vaccine containing hemagglutinin confers protection against 2009 H1N1 pandemic influenza.

Authors:  M Jaber Hossain; Melissa Bourgeois; Fu-Shi Quan; Aleksandr S Lipatov; Jae-Min Song; Li-Mei Chen; Richard W Compans; Ian York; Sang-Moo Kang; Ruben O Donis
Journal:  Clin Vaccine Immunol       Date:  2011-10-26

6.  Efficacy of an extract of North American ginseng containing poly-furanosyl-pyranosyl-saccharides for preventing upper respiratory tract infections: a randomized controlled trial.

Authors:  Gerald N Predy; Vinti Goel; Ray Lovlin; Allan Donner; Larry Stitt; Tapan K Basu
Journal:  CMAJ       Date:  2005-10-25       Impact factor: 8.262

7.  Panax notoginseng attenuates LPS-induced pro-inflammatory mediators in RAW264.7 cells.

Authors:  Ava Rhule; Severine Navarro; Jerry R Smith; David M Shepherd
Journal:  J Ethnopharmacol       Date:  2006-01-19       Impact factor: 4.360

8.  Virus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in mice.

Authors:  Fu-Shi Quan; Aswani Vunnava; Richard W Compans; Sang-Moo Kang
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

9.  Beneficial effects of a combination of Korean red ginseng and highly active antiretroviral therapy in human immunodeficiency virus type 1-infected patients.

Authors:  Heungsup Sung; You-Sun Jung; Young-Keol Cho
Journal:  Clin Vaccine Immunol       Date:  2009-06-17

10.  North American (Panax quinquefolius) and Asian Ginseng (Panax ginseng) Preparations for Prevention of the Common Cold in Healthy Adults: A Systematic Review.

Authors:  Jennifer Krebs Seida; Tamara Durec; Stefan Kuhle
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-14       Impact factor: 2.629

View more
  26 in total

Review 1.  Therapeutic potential of medicinal plants against COVID-19: The role of antiviral medicinal metabolites.

Authors:  Tariq Khan; Mubarak Ali Khan; Zia-Ur-Rehman Mashwani; Nazif Ullah; Akhtar Nadhman
Journal:  Biocatal Agric Biotechnol       Date:  2020-12-11

2.  Ginseng diminishes lung disease in mice immunized with formalin-inactivated respiratory syncytial virus after challenge by modulating host immune responses.

Authors:  Jong Seok Lee; Min Kyoung Cho; Hye Suk Hwang; Eun-Ju Ko; Yu-Na Lee; Young-Man Kwon; Min-Chul Kim; Ki-Hye Kim; Young-Tae Lee; Yu-Jin Jung; Sang-Moo Kang
Journal:  J Interferon Cytokine Res       Date:  2014-07-22       Impact factor: 2.607

Review 3.  Evolution of the adaptogenic concept from traditional use to medical systems: Pharmacology of stress- and aging-related diseases.

Authors:  Alexander G Panossian; Thomas Efferth; Alexander N Shikov; Olga N Pozharitskaya; Kenny Kuchta; Pulok K Mukherjee; Subhadip Banerjee; Michael Heinrich; Wanying Wu; De-An Guo; Hildebert Wagner
Journal:  Med Res Rev       Date:  2020-10-25       Impact factor: 12.944

4.  Total ginsenosides induce autophagic cell death in cervical cancer cells accompanied by downregulation of bone marrow stromal antigen-2.

Authors:  Shuai Bian; Yue Zhao; Fangyu Li; Shuyan Lu; Ziyan He; Siming Wang; Xueyuan Bai; Daqing Zhao; Meichen Liu; Jiawen Wang
Journal:  Exp Ther Med       Date:  2021-04-22       Impact factor: 2.447

Review 5.  Pharmacological effects of ginseng on infectious diseases.

Authors:  Nguyen H Nguyen; Cuong Thach Nguyen
Journal:  Inflammopharmacology       Date:  2019-08-12       Impact factor: 5.093

6.  Inhibitory effect of high temperature- and high pressure-treated red ginseng on exercise-induced oxidative stress in ICR mouse.

Authors:  Seok-Yeong Yu; Bo-Ra Yoon; Young-Jun Lee; Jong Seok Lee; Hee-Do Hong; Young-Chul Lee; Young-Chan Kim; Chang-Won Cho; Kyung-Tack Kim; Ok-Hwan Lee
Journal:  Nutrients       Date:  2014-03-07       Impact factor: 5.717

7.  Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo.

Authors:  Dongxi Xiang; Yang Zheng; Wei Duan; Xiujing Li; Jianjian Yin; Sarah Shigdar; Michael Liam O'Connor; Manju Marappan; Xiaojuan Zhao; Yingqiu Miao; Bin Xiang; Conglong Zheng
Journal:  Int J Nanomedicine       Date:  2013-10-30

8.  Red ginseng and H5N1 influenza infection.

Authors:  Viroj Wiwanitkit
Journal:  J Ginseng Res       Date:  2014-05-23       Impact factor: 6.060

9.  Protective effect of ginsenoside-Rb2 from Korean red ginseng on the lethal infection of haemagglutinating virus of Japan in mice.

Authors:  Yung Choon Yoo; Junglim Lee; Seok Rae Park; Ki Yeul Nam; Young Ho Cho; Jae Eul Choi
Journal:  J Ginseng Res       Date:  2013-03       Impact factor: 6.060

10.  Immunomodulatory activity of red ginseng against influenza A virus infection.

Authors:  Jong Seok Lee; Hye Suk Hwang; Eun-Ju Ko; Yu-Na Lee; Young-Man Kwon; Min-Chul Kim; Sang-Moo Kang
Journal:  Nutrients       Date:  2014-01-27       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.